Neuromodulation Device Prototyping

The contract seeks the development of minimally invasive or non-invasive neuromodulation technologies designed to precisely target neural circuits associated with neuroplasticity, with a focus on innovative approaches such as focused ultrasound, closed-loop implantable systems, and wearable stimulators. The goal is to advance therapeutic capabilities by enabling accurate, real-time modulation of neural activity without the need for traditional surgical intervention, supporting potential applications in neurological and psychiatric conditions. The project emphasizes engineering precision, biological compatibility, and clinical translatability in the design and prototyping phases. This is a subcontract opportunity under the Defense Advanced Research Projects Agency, part of the Department of Defense, classified under NAICS code 334510 for medical equipment manufacturing. The solicitation was posted on August 6, 2026, with a response deadline of August 14, 2026, indicating a narrow window for submissions. The place of performance and specific office address details are unspecified, suggesting flexibility in location for the contractor, though alignment with DoD research objectives and potential field testing requirements may influence implementation. Participation is expected to involve collaboration with government stakeholders to meet technical milestones and ensure compliance with defense-related innovation standards.